Primary hyperparathyroidism (PHPT) is one of main cause of morbidity in patients with multiple endocrine neoplasia type 1 (MEN1). Medical therapy with cinacalcet-hydrochloride may modify the therapeutic strategy of MEN1 related PHPT. We present an experience with cinacalcet-hydrochloride in two patients with MEN1 PHPT.
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 / Del Prete, M; Marotta, V; Ramundo, V; Marciello, F; Di Sarno, A; Esposito, R; Carratù, A C; De Luca Di Roseto, C; Di Somma, C; Colao, A; Faggiano, A. - In: MINERVA ENDOCRINOLOGICA. - ISSN 0391-1977. - 38:4(2013), pp. 389-394.
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1
Ramundo, V;Faggiano, A
2013
Abstract
Primary hyperparathyroidism (PHPT) is one of main cause of morbidity in patients with multiple endocrine neoplasia type 1 (MEN1). Medical therapy with cinacalcet-hydrochloride may modify the therapeutic strategy of MEN1 related PHPT. We present an experience with cinacalcet-hydrochloride in two patients with MEN1 PHPT.| File | Dimensione | Formato | |
|---|---|---|---|
|
DelPrete_Cinacalcet-hydrochloride_2013.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
430.22 kB
Formato
Adobe PDF
|
430.22 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
